Join Ibex at ECP 2023 in Dublin to learn how they transform cancer diagnosis by harnessing artificial intelligence to support routine practice at pathology labs worldwide. There will be three clinical presentations from studies conducted at...

HER2 IHC testing in the wake of the 2023 HER2 Breast Guideline Update Clinical Value, Classification & Scoring and the impact of the ASCO-CAP 2023 HER2 Breast Testing Guideline Update Over the past several months, the HER2/neu IHC...

Lunit, a firm specializing in cancer diagnostics and therapeutics powered by artificial intelligence (AI), announced the presentation of data from a collaborative study on the use of the Lunit SCOPE IO test to predict immunotherapy treatment...

Initial analyses also show AI screening lowers associated radiologist image reading workload by half Both radiologists and pathologists analyze images to make cancer diagnoses, although one works with radiological images and the other works...

Hoag and Imagene: Leveraging AI-based molecular profiling from a digitized biopsy image to enable physicians to gain immediate oncology intelligence. NEWPORT BEACH, Calif., August 15, 2023 (Newswire.com) - Hoag, the largest community-based...

From MIT News: Predictions from the OncoNPC model could enable doctors to choose targeted treatments for difficult-to-treat tumors. For a small percentage of cancer patients, doctors are unable to determine where their cancer originated....